Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
In the latest session, AnaptysBio Inc (NASDAQ: ANAB) closed at $23.66 down -1.74% from its previous closing price of $24.08. In other words, the price has decreased by -$1.74 from its previous closing price. On the day, 0.67 million shares were traded. ANAB stock price reached its highest trading level at $25.47 during the session, while it also had its lowest trading level at $23.32.
Ratios:
For a deeper understanding of AnaptysBio Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.23 and its Current Ratio is at 10.23. In the meantime, Its Debt-to-Equity ratio is 4.35 whereas as Long-Term Debt/Eq ratio is at 4.33.
On July 22, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $55.
JP Morgan Upgraded its Neutral to Overweight on July 19, 2024, whereas the target price for the stock was revised from $29 to $69.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 29 ’24 when RENTON HOLLINGS sold 10,000 shares for $25.00 per share. The transaction valued at 250,000 led to the insider holds 1,950 shares of the business.
HOLLINGS C RENTON bought 10,000 shares of ANAB for $250,000 on Nov 29 ’24. On Sep 23 ’24, another insider, Lizzul Paul F., who serves as the Chief Medical Officer of the company, sold 1,500 shares for $38.67 each. As a result, the insider received 58,005 and left with 15,398 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ANAB now has a Market Capitalization of 732721792 and an Enterprise Value of 656883648. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.59 while its Price-to-Book (P/B) ratio in mrq is 8.53. Its current Enterprise Value per Revenue stands at 11.49 whereas that against EBITDA is -4.711.
Stock Price History:
Over the past 52 weeks, ANAB has reached a high of $41.31, while it has fallen to a 52-week low of $14.75. The 50-Day Moving Average of the stock is -13.82%, while the 200-Day Moving Average is calculated to be -14.88%.
Shares Statistics:
For the past three months, ANAB has traded an average of 426.37K shares per day and 514340 over the past ten days. A total of 30.43M shares are outstanding, with a floating share count of 25.98M. Insiders hold about 14.63% of the company’s shares, while institutions hold 98.19% stake in the company. Shares short for ANAB as of 1731628800 were 6714227 with a Short Ratio of 15.75, compared to 1728950400 on 5977933. Therefore, it implies a Short% of Shares Outstanding of 6714227 and a Short% of Float of 30.130000000000003.
